期刊文献+

皮质基底节变性综合征四例临床及影像学分析 被引量:5

Clinical and neuroimaging analysis of 4 patients with corticobasal degeneration syndrome
原文传递
导出
摘要 目的探讨皮质基底节变性综合征的临床特征、影像学表现和治疗。方法对4例临床诊断皮质基底节变性患者的资料进行回顾性分析。结果4例患者的首发症状均为单侧肢体的帕金森样表现,对左旋多巴治疗无反应,4例均有肢体失用、构音障碍,3例伴肌阵挛,2例伴有痴呆,1例伴不自主运动。4例患者头部MRI扫描均显示受累肢体对侧脑皮质萎缩,以额顶叶显著;头葡萄糖代谢正电子发射断层扫描(FDG—PET)检查均显示不对称的大脑皮质和基底节区葡萄糖代谢减低。结论皮质基底节变性综合征患者的临床特征为不对称的帕金森样表现,可伴有认知功能障碍、失用、构音障碍、肌阵挛和不自主运动等症状;头MRI、FDG—PET检查有助于诊断;目前尚无有效治疗方法。 Objective To investigate clinical and imaging features of corticobasal degeneration syndrome ( CBDS ). Methods A clinical, imaging and therapeutic analysis of 4 cases of clinically diagnosed with corticobasal degeneration was conducted. Results Asymmetric parkinsonism was the first symptom in all 4 cases who lacked of response to levodopa. Other symptoms including limb apraxia and anarthria occurred in all 4 cases, myoclonus occurred in three, dementia occurred in two, and involuntary movement occurred in one. All the patients had asymmetric frontoparietal cortical atrophy in the eontra- lateral to the dominantly affected limbs on MRI. Asymmetric hypometabolism of the frontoparietal cortex and basal ganglia was observed on 18F-FDG PET in all 4 cases. Conclusions The clinical features of CBDS are asymmetric parkinsonism, dementia, apraxia, anarthria, myoclonus, and involuntary movement. Brain MRI and 18F-FDG PET are helpful to diagnosis of CBDS. There is no effective treatment for CBDS at this time.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2012年第8期595-599,共5页 Chinese Journal of Neurology
关键词 基底神经节 大脑皮质 诊断显像 Basal ganglia Cerebral cortex Diagnostic imaging
  • 相关文献

参考文献25

  • 1Doran M, du Plessis DG, Enevoldson TP, et al. Pathological heterogeneity of clinically diagnosed corticobasal degeneration, J Neurol Sci, 2003, 216 : 127-134.
  • 2Rebeiz J J, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol, 1968, 18: 20-33.
  • 3Mahapatra RK, Edwards MJ, Schott JM, et al. Corticobasal degeneration. Lancet Neurol, 2004,3:736-743.
  • 4朱明伟,王鲁宁,王振福,桂秋萍.皮质基底节变性的临床和病理研究[J].中华内科杂志,2002,41(11):732-735. 被引量:4
  • 5Katsuse O, Iseki E, Aria T, et al. 4-repeat tauopaphy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuelear palsy. Acta Ncuropaphol, 2003, 106:251-260.
  • 6Fu YJ, Nishihira Y, Kuroda S, et al. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism,and motonleuron disease : adistinct clinicopathological and biochemical disease entity. Acta Neuropathol, 2010,120:21-32.
  • 7Boeve BF. The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study. J Mol Neurosci ,2011,45:350-353.
  • 8Tartaglia MC, Sidhu M, Laluz V, et al. Sporadic corticobasal syndrome due to FTLD-TDP. Acta Neuropathol, 2010,119:365- 374.
  • 9Ling H, O' Sullivan SS, Holton JL, et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain, 2010,133 Pt 7:2045-2057.
  • 10Hassan A, Whitwell J, Boeve BF, et al. Symmetric corticobasal degeneration. Parkinsonism Relat Disord, 2010, 16:208-214.

二级参考文献12

  • 1Mitrak K, Gangopadhaya PK, Das SK.Parkinsonism plus syndrome.Neurol India,2003,51:183-188.
  • 2Ozawa T, Paviour D, Quinn NP, et al.The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy:clinicopathological correlations.Brain,2004,127:2657-2671.
  • 3Tu P, Galvin JE, Baha M, et al.Glial cytoplasmic inclusions in white matter ologodendrocytes of multiple system atrophy brain contain insoluble α-synuclein.Ann Neurol,1998,44:415-422.
  • 4Osaki Y, Ben-Shlomo Y, Wenning GK, et al.Dopublished criteria improve clinical diagnostic accuracy in Multiple system atrophy? Neurology,2002,49:1486-1491.
  • 5Gilman S, Low PA, Quinn NP, et al.Consensus statement on the diagnosis of multiple system atrophy.J Neurol Sci,1999,163:94-98.
  • 6Arai T, Ikeda K, Akiyama H, et al.Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.Acta Neuropathol,2001,101:167-173.
  • 7Dickson DW, Bergeron C, Chin SS, et al.Office of rare diseases neuropathologic criteria for corticobasal degeneration.J Neuropath Exp Neurol, 2002,61:935-946.
  • 8Katsuse O,Iseki E, Aria T, et al.4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.Acta Neuropathol,2003,106:251-260.
  • 9Lopez OL, Becker JT, Kaufer DI, et al.Research evaluation and prospective diagnosis of dementia with lewy bodies.Arch Neurol,2002,49:43-46.
  • 10Marui W, Iseki E, Kato M,et al.Pathological entity of dementia with lewy bodies and its differentiation from Alzheimer's disease.Acta Neuropathol,2004,108:121-128.

共引文献9

同被引文献54

  • 1郭起浩,洪震,于欢,吕传真,周燕.语义性痴呆的临床、认知和影像学特征研究—附3例报告[J].中华神经医学杂志,2004,3(5):363-365. 被引量:13
  • 2Knopman DS, Roberts RO. Estimating the number of persons with frontotemporal lobar degeneration in the US population [ J ]. J Mol Neurosci, 2011, 45 : 330-335.
  • 3Sehman RE, Matthews BR. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management [ J ]. CNS Drugs, 2012, 26: 841-870.
  • 4Sorbi S, Hort J, Erkinjuntti T, et al. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia[J]. EurJNeurol, 2012, 19: 1159-1179.
  • 5Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia[ J]. Brain, 2011, 134 Pt 9 : 2456-2477.
  • 6The Lund and Manchester Groups. Consensus Statement. Clinical and neuropathological criteria for fronto-temporal dementia [ J ]. J Neurol Neurosurg Psychiatry, 1994, 4 : 416-418.
  • 7Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria [ J ]. Neurology, 1998, 51: 1546-1554.
  • 8Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologie subtypes of frontotemporal lobar degeneration : an update[ J]. Acta Neuropathol, 2010, 119 : 1-4.
  • 9Rohrer JD, Guerreiro R, Vandrovcova J, et al. The heritability and genetics of frontotemporal lobar degeneration [ J ]. Neurology, 2009, 73 : 1451-1456.
  • 10DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noneoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS [ J ]. Neuron, 2011, 72 : 245-256.

引证文献5

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部